Coloplast (Denmark) Today
| COLO-B Stock | DKK 732.20 5.80 0.80% |
PerformanceVery Weak
| Odds Of DistressLow
|
Coloplast is trading at 732.20 as of the 19th of March 2025, a 0.80 percent up since the beginning of the trading day. The stock's open price was 726.4. Coloplast has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast operates under Healthcare Products classification in Denmark and is traded on Copenhagen Stock Exchange. The company has 194.31 M outstanding shares. More on Coloplast AS
Moving together with Coloplast Stock
Moving against Coloplast Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Coloplast Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Coloplast's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Coloplast or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Medical Instruments & Supplies, Healthcare (View all Sectors) |
Coloplast AS (COLO-B) is traded on Copenhagen Exchange in Denmark and employs 14,500 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 175.43 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Coloplast's market, we take the total number of its shares issued and multiply it by Coloplast's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Coloplast AS operates under Healthcare sector and is part of Medical Instruments & Supplies industry. The entity has 194.31 M outstanding shares.
Coloplast AS has accumulated about 620 M in cash with 5.1 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.92.
Check Coloplast Probability Of Bankruptcy
Ownership AllocationColoplast holds a total of 194.31 Million outstanding shares. Coloplast AS retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Coloplast Ownership Details
Coloplast AS Risk Profiles
Although Coloplast's alpha and beta are two of the key measurements used to evaluate Coloplast's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.817 | |||
| Standard Deviation | 1.13 | |||
| Variance | 1.27 | |||
| Risk Adjusted Performance | (0.17) |
Coloplast Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Coloplast without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Search Now
Equity SearchSearch for actively traded equities including funds and ETFs from over 30 global markets |
| All Next | Launch Module |
Coloplast Corporate Management
Elected by the shareholders, the Coloplast's board of directors comprises two types of representatives: Coloplast inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Coloplast. The board's role is to monitor Coloplast's management team and ensure that shareholders' interests are well served. Coloplast's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Coloplast's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ellen Bjurgert | VP Relations | Profile | |
| Allan Rasmussen | Ex Operations | Profile | |
| Alain Morvan | VP Europe | Profile | |
| Nicolai Andersen | Ex Innovation | Profile | |
| Thomas Barfod | Controller Director | Profile | |
| Anders LonningSkovgaard | Ex CFO | Profile | |
| Kristian Villumsen | Pres CEO | Profile |
Other Information on Investing in Coloplast Stock
Coloplast financial ratios help investors to determine whether Coloplast Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Coloplast with respect to the benefits of owning Coloplast security.